Total Payments
$1,106
2024 Payments
$47.54
Companies
13
Transactions
65
Medicare Patients
2,498
Medicare Billing
$672,209
Payment Breakdown by Category
Food & Beverage$1,106 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,106 | 65 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $226.12 | 18 | $0 (2021) |
| Paratek Pharmaceuticals, Inc. | $166.59 | 17 | $0 (2024) |
| CIPLA USA INC. | $163.75 | 1 | $0 (2021) |
| ABBVIE INC. | $120.14 | 7 | $0 (2024) |
| Allergan, Inc. | $120.13 | 7 | $0 (2020) |
| Smith+Nephew, Inc. | $78.97 | 4 | $0 (2021) |
| Medtronic Vascular, Inc. | $54.99 | 1 | $0 (2019) |
| Melinta Therapeutics, LLC | $54.53 | 4 | $0 (2022) |
| Organogenesis Inc. | $44.33 | 2 | $0 (2022) |
| Molnlycke Health Care US, LLC | $21.70 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47.54 | 3 | Paratek Pharmaceuticals, Inc. ($16.91) |
| 2023 | $26.69 | 2 | ABBVIE INC. ($26.69) |
| 2022 | $90.31 | 5 | ABBVIE INC. ($52.55) |
| 2021 | $420.24 | 21 | CIPLA USA INC. ($163.75) |
| 2020 | $115.19 | 7 | Merck Sharp & Dohme Corporation ($35.99) |
| 2019 | $196.75 | 10 | Medtronic Vascular, Inc. ($54.99) |
| 2018 | $36.44 | 2 | Allergan Inc. ($36.44) |
| 2017 | $172.61 | 15 | Merck Sharp & Dohme Corporation ($130.88) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/17/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/09/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: ANTIBIOTIC | ||||||
| 02/01/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: HIV | ||||||
| 06/15/2023 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/11/2023 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/30/2022 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $23.80 | General |
| Category: WOUND CARE | ||||||
| 11/10/2022 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/25/2022 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/19/2022 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Orbactiv, Vabomere | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: ANTIBIOTICS | ||||||
| 02/10/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/14/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/11/2021 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug), GRAFIX | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Pharma Product | ||||||
| 09/24/2021 | ORGANOGENESIS INC. | Puraply Antimicrobial (Medical Supply) | Food and Beverage | Cash or cash equivalent | $20.53 | General |
| Category: Wound Care | ||||||
| 09/09/2021 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $2.89 | General |
| Category: ANTIBIOTIC | ||||||
| 08/19/2021 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $4.47 | General |
| Category: ANTIBIOTIC | ||||||
| 08/05/2021 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $4.41 | General |
| Category: ANTIBIOTIC | ||||||
| 07/29/2021 | Merck Sharp & Dohme Corporation | DIFICID (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/29/2021 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: ANTIBIOTIC | ||||||
| 06/10/2021 | Merck Sharp & Dohme Corporation | DIFICID (Drug), RECARBRIO, ZINPLAVA | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/09/2021 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $30.16 | General |
| Category: Other Advanced Wound Management | ||||||
| 05/27/2021 | CIPLA USA INC. | ZEMDRI (PLAZOMICIN) (Drug) | Food and Beverage | Cash or cash equivalent | $163.75 | General |
| Category: ANTIBIOTICS | ||||||
| 05/27/2021 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $4.84 | General |
| Category: ANTIBIOTIC | ||||||
| 05/06/2021 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: ANTIBIOTIC | ||||||
| 04/22/2021 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: ANTIBIOTIC | ||||||
| 04/15/2021 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $9.12 | General |
| Category: ANTIBIOTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 464 | 2,262 | $617,719 | $163,362 |
| 2022 | 7 | 653 | 2,881 | $785,304 | $204,607 |
| 2021 | 7 | 589 | 1,646 | $505,392 | $129,400 |
| 2020 | 7 | 792 | 2,500 | $660,296 | $174,840 |
Total Patients
2,498
Total Services
9,289
Medicare Billing
$672,209
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 151 | 1,640 | $388,724 | $102,565 | 26.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 117 | 313 | $111,947 | $29,892 | 26.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 119 | 134 | $52,763 | $14,098 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 21 | 101 | $29,685 | $7,783 | 26.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 41 | 43 | $22,719 | $5,928 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 31 | $11,881 | $3,095 | 26.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 174 | 1,877 | $411,274 | $107,986 | 26.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 182 | 637 | $200,739 | $51,969 | 25.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 103 | 109 | $66,409 | $17,314 | 26.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 121 | 136 | $56,580 | $14,715 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 30 | 57 | $17,567 | $4,529 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 31 | $12,317 | $3,203 | 26.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 23 | $12,838 | $2,891 | 22.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $7,580 | $2,001 | 26.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 258 | 763 | $242,689 | $61,161 | 25.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 89 | 550 | $121,590 | $31,858 | 26.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 82 | 86 | $52,911 | $13,159 | 24.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 69 | 72 | $30,067 | $7,696 | 25.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 51 | $19,939 | $5,383 | 27.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 29 | 63 | $19,728 | $5,156 | 26.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $9,618 | $2,646 | 27.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 18 | 42 | $8,850 | $2,342 | 26.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 330 | 1,774 | $393,622 | $105,011 | 26.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 240 | 278 | $112,764 | $31,331 | 27.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 99 | 251 | $79,441 | $21,006 | 26.4% |
About Dr. Shariq Rauf, MD
Dr. Shariq Rauf, MD is a Internal Medicine healthcare provider based in Baytown, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528019023.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shariq Rauf, MD has received a total of $1,106 in payments from pharmaceutical and medical device companies, with $47.54 received in 2024. These payments were reported across 65 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,106).
As a Medicare-enrolled provider, Rauf has provided services to 2,498 Medicare beneficiaries, totaling 9,289 services with total Medicare billing of $672,209. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Infectious Disease
- Location Baytown, TX
- Active Since 05/12/2006
- Last Updated 06/16/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1528019023
Products in Payments
- DALVANCE (Drug) $178.65
- NUZYRA (Drug) $166.59
- ZEMDRI (PLAZOMICIN) (Drug) $163.75
- ZERBAXA (Drug) $162.92
- AVYCAZ (Drug) $61.62
- VenaSeal (Device) $54.99
- Baxdela (Drug) $40.57
- DIFICID (Drug) $40.52
- GRAFIX PL (Medical Supply) $30.16
- Santyl (Drug) $28.99
- Puraply (Medical Supply) $23.80
- NOXAFIL (Drug) $22.68
- AVANCE FLEX (Device) $21.70
- Puraply Antimicrobial (Medical Supply) $20.53
- RAPIVAB (Biological) $20.03
- COLLAGENASE SANTYL (Drug) $19.82
- Fetroja (Drug) $19.77
- DOVATO (Drug) $14.72
- Kimyrsa (Drug) $13.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Baytown
Dr. Dinara Rose, M.d, M.D
Internal Medicine — Payments: $7,729
Internal Medicine $7,729
Dr. Luis Gonzalez, M.d, M.D
Internal Medicine — Payments: $6,904
Internal Medicine $6,904
Atif Qureshi, M.d, M.D
Internal Medicine — Payments: $6,870
Internal Medicine $6,870
Shehzad Sami, Md, MD
Internal Medicine — Payments: $5,864
Internal Medicine $5,864
Kamran Khan, Md, MD
Internal Medicine — Payments: $4,512
Internal Medicine $4,512
Dr. Niravkumar Naik, M.d, M.D
Internal Medicine — Payments: $4,481
Internal Medicine $4,481